Pacific Biosciences Of California (PACB) Other Non-Current Assets (2016 - 2025)
Pacific Biosciences Of California has reported Other Non-Current Assets over the past 16 years, most recently at $8.8 million for Q4 2025.
- Quarterly results put Other Non-Current Assets at $8.8 million for Q4 2025, up 294.82% from a year ago — trailing twelve months through Dec 2025 was $8.8 million (up 294.82% YoY), and the annual figure for FY2025 was $8.8 million, up 294.82%.
- Other Non-Current Assets for Q4 2025 was $8.8 million at Pacific Biosciences Of California, up from $1.5 million in the prior quarter.
- Over the last five years, Other Non-Current Assets for PACB hit a ceiling of $8.8 million in Q4 2025 and a floor of $1.5 million in Q2 2025.
- Median Other Non-Current Assets over the past 5 years was $2.7 million (2023), compared with a mean of $3.3 million.
- Biggest five-year swings in Other Non-Current Assets: crashed 41.23% in 2023 and later soared 294.82% in 2025.
- Pacific Biosciences Of California's Other Non-Current Assets stood at $5.1 million in 2021, then crashed by 36.72% to $3.2 million in 2022, then dropped by 15.52% to $2.7 million in 2023, then fell by 18.37% to $2.2 million in 2024, then soared by 294.82% to $8.8 million in 2025.
- The last three reported values for Other Non-Current Assets were $8.8 million (Q4 2025), $1.5 million (Q3 2025), and $1.5 million (Q2 2025) per Business Quant data.